THE LUGANO CLASSIFICATION
BONE MARROW EVALUATION • HL If PET-CT is performed, bone marrow biopsy no longer indicated for HL • DLBCL Biopsy if the PET is negative and identifying a discordant histology is important for patient management • Other subtypes ~2.5 cm unilateral bone marrow biopsy is recommended, along with immunohistochemistry and flow cytometry at
Download THE LUGANO CLASSIFICATION
Information
Domain:
Source:
Link to this page:
Documents from same domain
PRINCIPLES OF CHEMOTHERAPY IN CANCER
oncologypro.esmo.org1. NEOADJUVANT CHEMOTHERAPY [PREOPERATIVELY] Rationale •To make non-operable tumors operable •To achieve organ preservation •To select sensitivity for specific treatment (biomarkers) 2. ADJUVANT CHEMOTHERAPY [POSTOPERATIVELY] Rationale •To kill micrometastatic disease •To increase disease-free survival 3. PALLIATIVE CHEMOTHERAPY
EPIDEMIOLOGY OF BREAST CANCER IN AFRICA
oncologypro.esmo.orgEPIDEMIOLOGY OF BREAST CANCER IN AFRICA Joe-Nat Clegg-Lamptey School of Medicine and Dentistry, University of Ghana 1. I have no conflict of interest. Breast Cancer in Africa: Epidemiology •Incidence: Moderate but Increasing •Young age of patients •Advanced disease / Long duration of symptoms
CYP3A4 Inhibitor/Inducer Drug-drug Interactions for all ...
oncologypro.esmo.orgAfter discontinuation of a strong CYP3A4 inhibitor resume the dose that was taken prior to initiating the strong CYP3A4 inhibitor Avoid concurrent use of strong CYP3A inducers Crizotinib Ketoconazole Rifampicin Extreme caution should be taken if co-administration with a CYP3A4 inhibitor is unavoidable, the crizotinib dose should be
CLINICAL TRIAL ENDPOINTS - OncologyPRO
oncologypro.esmo.orgESMO Clinical Trials Tips and Tricks: Clinical Trial Endpoints Author: Ian Tannock, Steinar Aamdal, Dirk Arnold, Urania Dafni, Ulrich Keilholz, Morten Mau-Sørensen, Piotr Rutkowski, Stefan Sleijfer Subject: ESMO Clinical Trials Tips and Tricks: Clinical Trial Endpoints Created Date: 12/4/2015 12:53:31 PM
UNDERSTANDING CLINICAL TRIAL STATISTICS
oncologypro.esmo.orgUNDERSTANDING CLINICAL TRIAL STATISTICS. Prepared by Urania Dafni, Xanthi ... EaSt 6.3.1: a software package for the design and interim monitoring of group sequential clinical trials, Cytel Software Corporation, Cambridge, MA, ... Understanding Clinical Trials Statistics
Related documents
Surgical Pathology
a1.mayomedicallaboratories.comSurgical Pathology Any UNLISTED specimen should be assigned to the CPT code which most closely reflects the work involved when compared to other specimens assigned to that code. The unit of service for CPT codes 88300 - 88309 is the SPECIMEN.A specimen …
ACUTE MYELOGENOUS LEUKEMIA (Including Acute …
www.who.int• Bone marrow aspirates are part of the routine evaluation of AML. In scenario’s where there is a “dry tap” or absence of material in the aspirate, a bone marrow biopsy will also be required. Otherwise a biopsy is not required for standard evaluation and care. Smears (touch preps) of the biopsy should also be evaluated. • This ...
Bone Marrow Transplantation in Mice - New York University
dental.nyu.eduOnce the marrows are flushed, a sterile Pasteur pipette or plastic transfer pipette is used to aspirate the cell suspension. A minimum of 35 aspirations will insure adequate dispersal of the cells. This can be verified visually with hemocytometer. The bone marrow disperses quite readily. An aliquot of the
Multiple Myeloma
www.albertahealthservices.ca• Bone marrow aspirate and biopsy • Skeletal survey The following tests should be obtained . yearly. thereafter: • CBC • Serum creatinine • Calcium, • Serum, and 24-hour urine protein electrophoresis • Quantitative immunoglobulins • Free light chains • Skeletal survey . Page 7 of 62
Hodgkin Lymphoma Early Detection, Diagnosis, and Staging
www.cancer.orgMar 28, 2017 · A bone marrow biopsy is usually done just after the aspiration. A small piece or core of bone and marrow is removed with a slightly larger needle that's pushed into the bone. The biopsy may also cause some brief pain. Most children having a bone marrow aspiration and biopsy are either given medicine to
Multiple Myeloma Early Detection, Diagnosis, and Staging
www.cancer.orgFeb 28, 2018 · The bone marrow tissue is examined in the lab to see the appearance, size, and shape of the cells, how the cells are arranged and to determine if there are myeloma cells in the bone marrow and, if so, how many. The aspirate (the liquid part of the bone marrow) may also be sent for other tests, including immunohistochemistry and flow cytometry,
Minimal Residual Disease (MRD)
www.lls.orgThese tests use samples of bone marrow cells (taken by aspiration) and/or peripheral blood cells (taken through a vein). Flow Cytometry. Flow cytometry is a technique that evaluates individual cells by checking for the presence or the absence of certain protein markers on the cell surface. A fresh bone marrow aspirate sample is required
UNDERSTANDING MULTIPLE MYELOMA AND LABORATORY …
www.lls.orgSmall fragments of bone marrow cells can be withdrawn with an aspirate needle, and a small core of bone and marrow is often removed at the same time with a different type of needle. Both tests are done to determine how much of the normal bone marrow is replaced by myeloma cells. Additional, specialized testing (cytogenetics and FISH)
NCCN Guidelines for Patients: Acute Myeloid Leukemia
www.nccn.orgDec 02, 2021 · Bone marrow is the sponge-like tissue in the center of most bones. Inside your bone marrow are early blood-forming cells called blood stem cells (hematopoietic stem cells). All types of blood cells start as blood stem cells. At any given time, bone marrow will have cells in various stages of development, from very immature to almost fully mature.